Great Basin Scientific, Inc. (Nasdaq: GBSN) announced it has initiated a clinical trial for its sample-to-result Bordatella Direct Test, which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE